ST. PAUL, Minn. – Patterson Companies, Inc. (NASDAQ:), a prominent distributor in dental and animal health, is set to be acquired by health care investment firm Patient Square Capital, following the expiration of a “go-shop” period on January 19, 2025. The agreement, which was previously announced, will see Patient Square Capital purchasing Patterson at $31.35 per share, in an all-cash transaction valued at roughly $4.1 billion, including the refinancing of Patterson’s receivables facilities.
During the 40-day go-shop period, Patterson had the opportunity to solicit and consider alternative proposals. However, no such proposals were received by the deadline. The transaction is anticipated to close in April 2025, subject to customary closing conditions, including approval from Patterson’s shareholders and antitrust clearance in the U.S. Once the deal is finalized, Patterson will operate as a privately held entity, and its shares will cease to be listed on the .
Patterson Companies has established itself as a connector of customers in North America and the U.K. to a broad range of products, technologies, and business solutions in the dental and animal health sectors. The company has maintained a solid financial position, with InvestingPro analysis showing consistent profitability and a 3.37% dividend yield, having maintained dividend payments for 15 consecutive years. Patient Square Capital, the acquiring firm, manages approximately $11 billion in assets and focuses on investments in health care entities that aim to enhance health outcomes.
The forthcoming acquisition is expected to position Patterson to leverage Patient Square Capital’s resources and health care industry expertise, although the specifics of how the transaction will influence Patterson’s operations or strategic direction have not been disclosed.
This press release contains forward-looking statements regarding the proposed merger, including the timing and completion of the transaction. It notes that the actual results may differ due to a variety of factors, and emphasizes the risks and uncertainties associated with such forward-looking statements.
Shareholders of Patterson will be asked to vote on the proposed merger at a special meeting, the details of which will be provided in a proxy statement to be filed with the SEC. The statement will offer important information about the merger and will be made available to shareholders for review. According to InvestingPro analysis, Patterson…
Click Here to Read the Full Original Article at All News…
